Adjuvant effects of sophy β-glucan on H5N1 and H5N2 vaccination using a mouse model

Tropical Medicine and Health

Volumn 38, Issue 1, 2010, Pages 23-27

  Le, Thanh Hoa ^a   Le, Kim Xuyen Thi ^a   Cuong, Pham Viet ^a   Cuc, Nguyen Thi Kim ^a   Le, Tran Binh ^a   Ikeue, Yasunori ^b   Watanabe, Yoshiya ^b   Agatsuma, Takeshi ^c  

^a INSTITUTE OF BIOTECHNOLOGY   (Viet Nam)

^b Research and Development Division   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

glucan; Avian influenza; H5N1 and H5N2 vaccine; Immunostimulation

Indexed keywords

BETA GLUCAN; DRINKING WATER; IMMUNOGLOBULIN G; INFLUENZA VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUREOBASIDIUM PULLULANS; CHINA; CONTROLLED STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; IMMUNE RESPONSE; INFLUENZA; INFLUENZA A (H5N1); INFLUENZA A (H5N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; MALE; MOUSE; NONHUMAN; SEROCONVERSION; TREATMENT OUTCOME; VIET NAM;

EID: 77953471574     PISSN: 13488945     EISSN: 13494147     Source Type: Journal    
DOI: 10.2149/tmh.2009-13     Document Type: Article

References (13)

1. Manners DJ, Mason AJ, Patterson JC. The structure of a ß-(1-3)-glucan from yeast cell walls. Biochem. J. 1973; 135: 19-30.
2. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 1999; 19: 65-96.
3. Shen J, Ren H, Tomiyama-Miyaji C, Suga Y, Suga T, Kuwano Y, Iiai T, Hatakeyama K, Abo T. (2007). Potentiation of intestinal immunity by micellary mushroom extracts. Biomed Res. 2007; 28:71-77.
4. Brown GD, Gordon S. Immune recognition of fungal ß-glucans. Cell Microbiol. 2005; 7: 471-479.
5. Dritz SS, Shi J, Kielian TL, Goodband RD, Nelssen JL, Tokach MD, Chengappa MM, Smith JE, Blecha F. Influence of dietary ß-glucan on growth performance, nonspecific immunity, and resistance to Streptococcus suis infection in weanling pigs. J Anim Sci. 1995; 73: 3341-3350.
6. Mushiake H, Tsunoda T, Nukatsuka M, Shimao K, Fukushima M, Tahara H. Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo. Cancer Immunol Immunother. 2005; 54: 120-128.
7. Chen HL, Li DF, Chang BY, Gong LM, Piao XS, Yi GF, Zhang JX. Effects of lentinan on broiler splenocyte proliferation, interleukin-2 production, and signal transduction. Poult Sci. 2003; 82(5): 760-766.
8. Ikewaki N, Fujii N, Onaka T, Ikewaki S, Inoko H. Immunological actions of Sophy ß-glucan (ß-1,3-1,6 glucan), currently available commercially as a health food supplement. Microbiol Immunol. 2007; 51(9): 861-873.
9. Berner VK, Sura ME, Hunter KW Jr. Conjugation of protein antigen to microparticulate ß-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations. Appl Microbiol Biotechnol. 2008; 80: 1053-1061.
10. WHO (2002). Manual on Animal Influenza Diagnosis and Surveillance.
11. Hobson D, Curry RL, Beare AS, and Ward-Gardner A. The role of serum haemagglutinationinhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. 1972; 70: 767-777.
12. DiNapoli JM, Yang L, Suguitan A Jr, Elankumaran S, Dorward DW, Murphy BR, Samal SK, Collins PL, Bukreyev A. Immunization of primates with a Newcastle disease virusvectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol. 2007; 81(21): 11560-11568.
13. Li B, Cramer D, Wagner S, Hansen R, King C, Kakar S, Ding C, Yan J. Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88-and Syk kinase-dependent pathways. Clin Immunol. 2007; 124: 170-181.